These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12756834

  • 1. [Dishonesty in clinical trials is expensive for the society].
    Gøtzsche PC.
    Ugeskr Laeger; 2003 Apr 14; 165(16):1691-2. PubMed ID: 12756834
    [No Abstract] [Full Text] [Related]

  • 2. [Dishonesty in clinical trials is expensive for the society 1].
    Heslet L, Nielsen JD, Schierbeck J.
    Ugeskr Laeger; 2003 Jun 23; 165(26):2671-2. PubMed ID: 12886555
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE.
    CMAJ; 2002 May 14; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Contact to the Danish Committees on Scientific Dishonesty is the logical step].
    Jensen IS.
    Ugeskr Laeger; 2009 Apr 06; 171(15):1308; author reply 1308. PubMed ID: 19422162
    [No Abstract] [Full Text] [Related]

  • 8. Profits, pressure, and perception: expensive research collides with medicine.
    Hoey J.
    J Rheumatol; 2003 Aug 06; 30(8):1661-2. PubMed ID: 12913915
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Drug development costs are overstated by the industry].
    Jeppsson A.
    Lakartidningen; 2003 Aug 06; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study agreements and budgets.
    McJilton JS.
    Epilepsy Res Suppl; 1993 Aug 06; 10():185-91. PubMed ID: 8251095
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [No bluff to be discovered in clinical trials].
    Berglund T.
    Lakartidningen; 1993 Aug 06; 106(13):952-3. PubMed ID: 19441200
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Is society going to finance projects of drug companies?].
    Bake B.
    Lakartidningen; 1999 May 12; 96(19):2327-8. PubMed ID: 10377674
    [No Abstract] [Full Text] [Related]

  • 20. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C.
    Lakartidningen; 1999 May 12; 106(7):450. PubMed ID: 19350775
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.